Wang, H., Wang, X., Li, Y., Wang, P., Zhang, X., Pan, Y., Cheng, R., Xiao, J. (2025). Neoadjuvant PD-1 inhibitor combined with Nab-paclitaxel and cisplatin in resectable locally advanced head and neck squamous cell carcinoma (NCT05522985): A randomized, controlled, open label, phase II clinical trial.. Journal of Clinical Oncology. https://doi.org/10.1200/jco.2025.43.16_suppl.6018